SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Markus Hoffermann, Lukas Bruckmann, Kariem Mahdy Ali, Martin Asslaber, Franz Payer, Gord von Campe, Treatment results and outcome in elderly patients with glioblastoma multiforme – A retrospective single institution analysis, Clinical Neurology and Neurosurgery, 2015, 128, 60

    CrossRef

  2. 2
    Masaya Miyazaki, Hiroshi Nishihara, Shunsuke Terasaka, Hiroyuki Kobayashi, Shigeru Yamaguchi, Tamio Ito, Yuuta Kamoshima, Shin Fujimoto, Sadao Kaneko, Masahito Katoh, Nobuaki Ishii, Hiromi Mohri, Mishie Tanino, Taichi Kimura, Shinya Tanaka, Immunohistochemical evaluation of O6-methylguanine DNA methyltransferase (MGMT) expression in 117 cases of glioblastoma, Neuropathology, 2014, 34, 3
  3. 3
    U. M. Upadhyay, B. Tyler, Y. Patta, R. Wicks, K. Spencer, A. Scott, B. Masi, L. Hwang, R. Grossman, M. Cima, H. Brem, R. Langer, Intracranial microcapsule chemotherapy delivery for the localized treatment of rodent metastatic breast adenocarcinoma in the brain, Proceedings of the National Academy of Sciences, 2014, 111, 45, 16071

    CrossRef

  4. 4
    Chih-Yi Hsu, Hsiang-Ling Ho, Yi-Chun Chang-Chien, Yi-Wen Chang, Donald Ming-Tak Ho, MGMT promoter methylation in non-neoplastic brain, Journal of Neuro-Oncology, 2014,

    CrossRef

  5. 5
    Valentina Fiano, Morena Trevisan, Elisa Trevisan, Rebecca Senetta, Anna Castiglione, Carlotta Sacerdote, Anna Gillio-Tos, Laura De Marco, Chiara Grasso, Michela Magistrello, Fabrizio Tondat, Roberta Rudà, Paola Cassoni, Riccardo Soffietti, Franco Merletti, MGMT promoter methylation in plasma of glioma patients receiving temozolomide, Journal of Neuro-Oncology, 2014, 117, 2, 347

    CrossRef

  6. 6
    Riccardo Soffietti, Luca Bertero, Lorenzo Pinessi, Roberta Rudà, Pharmacologic Therapies for Malignant Glioma: A Guide for Clinicians, CNS Drugs, 2014,

    CrossRef

  7. 7
    C-H Fan, W-L Liu, H Cao, C Wen, L Chen, G Jiang, O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas, Cell Death and Disease, 2013, 4, 10, e876

    CrossRef

  8. 8
    A. Gutenberg, C. B. Lumenta, W. E. K. Braunsdorf, M. Sabel, H. M. Mehdorn, M. Westphal, A. Giese, The combination of carmustine wafers and temozolomide for the treatment of malignant gliomas. A comprehensive review of the rationale and clinical experience, Journal of Neuro-Oncology, 2013, 113, 2, 163

    CrossRef

  9. 9
    Kui Zhang, Xiao-qin Wang, Bin Zhou, Lin Zhang, The prognostic value of MGMT promoter methylation in Glioblastoma multiforme: a meta-analysis, Familial Cancer, 2013, 12, 3, 449

    CrossRef

  10. 10
    Amade Bregy, Ashish H Shah, Maria V Diaz, Hayley E Pierce, Philip L Ames, Daniel Diaz, Ricardo J Komotar, The role of Gliadel wafers in the treatment of high-grade gliomas, Expert Review of Anticancer Therapy, 2013, 13, 12, 1453

    CrossRef

  11. 11
    Domenico d’Avella, Alessandro DellaPuppa, Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastomas, Acta Neurochirurgica, 2012, 154, 8, 1379

    CrossRef

  12. 12
    Monika Szeliga, Agata Zgrzywa, Marta Obara-Michlewska, Jan Albrecht, Transfection of a human glioblastoma cell line with liver-type glutaminase (LGA) down-regulates the expression of DNA-repair gene MGMT and sensitizes the cells to alkylating agents, Journal of Neurochemistry, 2012, 123, 3